# Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)

> **NCT00109382** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Calgary** · enrollment: 500 (estimated)

## Conditions studied

- Transient Ischemic Attack
- Stroke

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Clopidogrel
- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00109382
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-05
- **Primary completion:** —
- **Final completion:** 2007-02
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2008-04-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00109382

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00109382, "Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00109382. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*